Table 2.

True randomized trials of adjuvant HAI FUDR

StudiesSurvivaln% 2 Year% 5 YearP
HAISYSHAISYS
MSKCC (51)Hepatic progression-free156906075400.0001
ECOG (50)757550*7040*0.0001
Lorenz (46)186Median43/27*NS
Lygidakis (49)122927573600.0001
MSKCC (51)Disease-free156554040300.02
ECOG (50)7560404020*0.03
Lorenz (46)186Median20/12.6*NS
Lygidakis (49)122664860350.0002

Abbreviations: SYS, systemic treatment; NS, not significant.

  • *No treatment in control arm.